CYP3A5*3基因多态性在咪达唑仑肠道和肝脏代谢中无作用。 - Suppr

No role for the CYP3A5*3 polymorphism in intestinal and hepatic metabolism of midazolam.

作者信息

Tomalik-Scharte D, Doroshyenko O, Kirchheiner J, Jetter A, Lazar A, Klaassen T, Frank D, Wyen C, Fätkenheuer G, Fuhr U

出版信息

Eur J Clin Pharmacol. 2008 Oct;64(10):1033-5. doi: 10.1007/s00228-008-0503-9. Epub 2008 Jun 28.

DOI:10.1007/s00228-008-0503-9

PMID:18587567

Abstract

摘要

相似文献

No role for the CYP3A5*3 polymorphism in intestinal and hepatic metabolism of midazolam.

Eur J Clin Pharmacol. 2008 Oct;64(10):1033-5. doi: 10.1007/s00228-008-0503-9. Epub 2008 Jun 28.

Effects of the CYP oxidoreductase Ala503Val polymorphism on CYP3A activity in vivo: a randomized, open-label, crossover study in healthy Chinese men.

Clin Ther. 2011 Dec;33(12):2060-70. doi: 10.1016/j.clinthera.2011.11.004.

Urinary metabolic markers reflect on hepatic, not intestinal, CYP3A activity in healthy subjects.

Drug Metab Pharmacokinet. 2021 Feb;36:100374. doi: 10.1016/j.dmpk.2020.12.001. Epub 2020 Dec 3.

Genotype-phenotype associations for common CYP3A4 and CYP3A5 variants in the basal and induced metabolism of midazolam in European- and African-American men and women.

Pharmacogenetics. 2003 Oct;13(10):595-606. doi: 10.1097/00008571-200310000-00003.

Sex-dependent differences in cytochrome P450 3A activity as assessed by midazolam disposition in humans: a meta-analysis.

Drug Metab Dispos. 2010 May;38(5):817-23. doi: 10.1124/dmd.109.031328. Epub 2010 Feb 17.

Characterization of Intestinal and Hepatic CYP3A-Mediated Metabolism of Midazolam in Children Using a Physiological Population Pharmacokinetic Modelling Approach.

Pharm Res. 2018 Jul 30;35(9):182. doi: 10.1007/s11095-018-2458-6.

Dose-dependent intestinal and hepatic first-pass metabolism of midazolam, a cytochrome P450 3A substrate with differently modulated enzyme activity in rats.

J Pharm Pharmacol. 1999 Jan;51(1):67-72. doi: 10.1211/0022357991771971.

Intestinal CYP3A4 and midazolam disposition in vivo associate with VDR polymorphisms and show seasonal variation.

Biochem Pharmacol. 2012 Jul 1;84(1):104-12. doi: 10.1016/j.bcp.2012.03.017. Epub 2012 Mar 30.

Inhibition of human intestinal wall metabolism by macrolide antibiotics: effect of clarithromycin on cytochrome P450 3A4/5 activity and expression.

Clin Pharmacol Ther. 2005 Mar;77(3):178-88. doi: 10.1016/j.clpt.2004.10.002.

First-Pass CYP3A-Mediated Metabolism of Midazolam in the Gut Wall and Liver in Preterm Neonates.

CPT Pharmacometrics Syst Pharmacol. 2018 Jun;7(6):374-383. doi: 10.1002/psp4.12295. Epub 2018 May 10.

引用本文的文献

Impaired hepatic drug and steroid metabolism in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency.

Eur J Endocrinol. 2010 Dec;163(6):919-24. doi: 10.1530/EJE-10-0764. Epub 2010 Sep 15.

本文引用的文献

Influence of CYP3A5 genotype on the pharmacokinetics and pharmacodynamics of the cytochrome P4503A probes alfentanil and midazolam.

Clin Pharmacol Ther. 2007 Oct;82(4):410-26. doi: 10.1038/sj.clpt.6100237. Epub 2007 Jun 6.

Effect of propiverine on cytochrome P450 enzymes: a cocktail interaction study in healthy volunteers.

Drug Metab Dispos. 2005 Dec;33(12):1859-66. doi: 10.1124/dmd.105.005272. Epub 2005 Sep 23.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

No role for the CYP3A5*3 polymorphism in intestinal and hepatic metabolism of midazolam.

作者信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献